WHO ICTRP trial
Possible efficacy and mechanism of siglitine in diabetic peripheral neuropathy
ChiCTR1900027394 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR1900027394 |
|---|---|
| Public title | Possible efficacy and mechanism of siglitine in diabetic peripheral neuropathy |
| Scientific title | Possible protective effect of siglitine versus acarbose on diabetic peripheral neuropathy: a randomized controlled study |
| Primary sponsor | South Hospital of Fujian Provincial Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | diabetic peripheral neuropathy |
| Interventions | observation group:Sitagliptin;control group:acarbose |
| Registration date | Nov 11, 2019 |
| Target size | observation group:25;control group:25 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: